Torrent Pharmaceuticals Ltd. (TORNTPHARM) Share Price Hits 52-Week High
- July 31, 2026
- Posted by: Harsh Piplani
- Category: News
Torrent Pharmaceuticals Ltd. Share Price has reached a fresh 52-week high of Rs 5,139.3, marking a significant milestone for the company. The stock opened at Rs 4,969.1 and closed at Rs 5,114.8, reflecting a day change of Rs 244.15 or 5.01%. With a market capitalisation of Rs 1,85,520.62 Cr, this achievement underscores the company’s strong presence in the healthcare sector. The surge in share price has captured the attention of investors, highlighting the importance of tracking Torrent Pharmaceuticals Ltd. Share Price Today for further insights.
Torrent Pharmaceuticals Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,114.8 |
| Previous Close | Rs 4,870.65 |
| Today's Change | +Rs 244.15 (+5.01%) |
| Day Open | Rs 4,969.1 |
| Fresh 52-Week High | Rs 5,139.3 |
| Day Low | Rs 4,894.9 |
| Current Volume | 2,86,442 |
| Turnover | Rs 146.51 crore |
| Market Capitalisation | Rs 1,85,520.62 crore |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) traded at Rs 5,114.8. versus the previous close of Rs 4,870.65, a rise of 5.01%. The stock opened at Rs 4,969.1, reached Rs 5,139.3, touched Rs 4,894.9. Reported volume was 2,86,442.
Today’s trading session saw Torrent Pharmaceuticals Ltd. Share Price reach a new 52-week high of Rs 5,139.3. The stock opened at Rs 4,969.1 and fluctuated between a low of Rs 4,894.9 and a high of Rs 5,139.3. The turnover for the day was Rs 146.51 Cr with a volume of 2,86,442 shares, indicating robust trading activity. The stock’s performance today highlights its upward momentum, making it a focal point for investors seeking to understand the dynamics behind the price movement.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,85,520.62 crore |
| P/E Ratio | 39.17x |
| P/B Ratio | 7.93x |
| ROE | 28.21% |
| ROCE | 26.35% |
Torrent Pharmaceuticals Ltd. was valued at a P/E ratio of 39.17x, a P/B ratio of 7.93x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 39.17x |
| Benchmark Median P/E | 20.13x |
| Benchmark Average P/E | 73.73x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 7.93x |
| Benchmark Median P/B | 1.92x |
| Company ROE | 28.21% |
| Benchmark Median ROE | 10.73% |
| Company ROCE | 26.35% |
| Benchmark Median ROCE | 13.2% |
| Company Market Capitalisation | Rs 1,85,520.62 crore |
| Benchmark Median Market Cap | Rs 140.91 crore |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) is classified under sector: Healthcare.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a P/E ratio of 39.17x, which is above the benchmark median of 20.13x, a difference of +94.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a ROE of 28.21%, which is above the benchmark median of 10.73%, a difference of +162.91%. Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a ROCE of 26.35%, which is above the benchmark median of 13.2%, a difference of +99.62%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd. | KPL | 2,700.98 | 39.17 | 7.93 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,475.7 | 58.88 | 9.32 | 18.65 | 22.17 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,439.14 | 165.82 | 3.06 | 13.9 | 12.97 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,424.44 | 34.59 | 7 | -2.6 | 16.92 |
| Venus Remedies Ltd. | VENUSREM-BE | 2,150.28 | 17.79 | 3.01 | 9.85 | 7.89 |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a P/E ratio of 39.17x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Torrent Pharmaceuticals Ltd. (TORNTPHARM) has a market capitalisation of Rs 1,85,520.62 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Torrent Pharmaceuticals Ltd.
- Fresh 52-week high at Rs 5,139.3, indicating strong price momentum.
- Robust trading activity with a turnover of Rs 146.51 Cr.
- Strong fundamentals with high ROE and ROCE.
- Competitive position in the healthcare sector.
- Outperformance relative to peers in profitability metrics.
About Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. is a prominent player in the healthcare sector, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company operates across various therapeutic segments, providing a wide range of medications to address diverse health needs. With a strong emphasis on research and development, Torrent Pharmaceuticals Ltd. continues to innovate and expand its product portfolio, catering to both domestic and international markets. Its strategic initiatives and robust operational framework have solidified its position as a leader in the pharmaceutical industry.
Track Torrent Pharmaceuticals Ltd. Share Price on Univest
Use Torrent Pharmaceuticals Ltd. (TORNTPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Torrent Pharmaceuticals Ltd. Share Price, along with technical indicators, fundamental ratios, shareholding patterns, and 52-week levels on Univest. Stay informed with the latest market insights and developments to make well-informed investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Torrent Pharmaceuticals Ltd.?
Ans. The current share price of Torrent Pharmaceuticals Ltd. is Rs 5,114.8, reflecting a 5.01% increase from the previous close, reaching a fresh 52-week high of Rs 5,139.3. The stock moved 5.01% during the session.
How did Torrent Pharmaceuticals Ltd. perform today?
Ans. Torrent Pharmaceuticals Ltd. opened at Rs 4,969.1, reached a high of Rs 5,139.3, and closed at Rs 5,114.8, with a turnover of Rs 146.51 Cr and a volume of 2,86,442 shares.
What is the market capitalisation of Torrent Pharmaceuticals Ltd.?
Ans. Torrent Pharmaceuticals Ltd. has a market capitalisation of Rs 1,85,520.62 Cr, positioning it as a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.17x.
How does Torrent Pharmaceuticals Ltd.'s P/E ratio compare to the sector?
Ans. Torrent Pharmaceuticals Ltd.'s P/E ratio of 39.17 is above the sector median of 20.13 but below the sector average of 73.73, indicating a competitive valuation. The company trades at a P/E ratio of 39.17x.
What are the profitability metrics of Torrent Pharmaceuticals Ltd.?
Ans. Torrent Pharmaceuticals Ltd. has a return on equity (ROE) of 28.21% and a return on capital employed (ROCE) of 26.35%, showcasing strong profitability. ROE stands at 28.21%. ROCE stands at 26.35%.
Who are the peers of Torrent Pharmaceuticals Ltd.?
Ans. Peers of Torrent Pharmaceuticals Ltd. include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd., Dr Agarwals Eye Hospital Ltd., and Venus Remedies Ltd. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd.
How does Torrent Pharmaceuticals Ltd.'s ROE compare to its peers?
Ans. Torrent Pharmaceuticals Ltd.'s ROE of 28.21% is higher than most of its peers, indicating superior profitability and efficient use of equity. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.
What is the significance of Torrent Pharmaceuticals Ltd.'s 52-week high?
Ans. The 52-week high of Rs 5,139.3 signifies strong investor confidence and positive market sentiment towards Torrent Pharmaceuticals Ltd. The stock moved 5.01% during the session. The intraday range extended from Rs 4,894.9 to Rs 5,139.3.
How can investors track Torrent Pharmaceuticals Ltd. Share Price?
Ans. Investors can track Torrent Pharmaceuticals Ltd. Share Price, technical indicators, and market insights on Univest for comprehensive analysis and updates. The stock moved 5.01% during the session. The intraday range extended from Rs 4,894.9 to Rs 5,139.3.
